< Back to previous page
Researcher
Muhammad Usman Mirza
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences, Bioinformatics and computational biology
Affiliations
- Medicinal Chemistry (Rega Institute) (Division)
Member
From10 Oct 2016 → 5 Nov 2020
Projects
1 - 1 of 1
- Drug design strategies against newly emerging viral diseasesFrom17 Oct 2016 → 30 Oct 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 37
- Engineering processive cellulase of Clostridium thermocellum to divulge the role of the carbohydrate-binding module(2023)
Authors: Muhammad Usman Mirza
Pages: 290 - 305 - Folate Conjugated Polyethylene Glycol Probe for Tumor-Targeted Drug Delivery of 5-Fluorouracil(2022)
Authors: Muhammad Usman Mirza
- Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro(2021)
Authors: Muhammad Usman Mirza, Mathy Froeyen
Pages: 4936 - 4948 - Impact of IL-17F 7488T/C Functional Polymorphism on Progressive Rheumatoid Arthritis: Novel Insight from the Molecular Dynamic Simulations(2021)
Authors: Muhammad Usman Mirza
Pages: 416 - 426 - Designing multi-epitope vaccine against Staphylococcus aureus by employing subtractive proteomics, reverse vaccinology and immuno-informatics approaches(2021)
Authors: Muhammad Usman Mirza
- Toxicological Screening of 4-Phenyl-3,4-dihydrobenzo[h]quinolin-2(1H)-one: A New Potential Candidate for Alzheimer's Treatment(2021)
Authors: Muhammad Usman Mirza
Pages: 10897 - 10909 - Effect of Berberis vulgaris L. root extract on ifosfamide-induced in vivo toxicity and in vitro cytotoxicity(2021)
Authors: Mathy Froeyen, Muhammad Usman Mirza
- Identification of novel human USP2 inhibitor and its putative role in treatment of COVID-19 by inhibiting SARS-CoV-2 papain-like (PLpro) protease(2020)
Authors: Muhammad Usman Mirza, Mathy Froeyen
- Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach(2020)
Authors: Muhammad Usman Mirza, Michiel Vanmeert, Steven De Jonghe, Dominique Schols, Mathy Froeyen
- New naphthalene derivative for cost-effective AChE inhibitors for Alzheimer's treatment: In silico identification, in vitro and in vivo validation(2020)
Authors: Mathy Froeyen, Muhammad Usman Mirza